This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Astrazeneca Ab, University of Cambridge. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2025
Title: The Innovations of Stephen James Walsh
Introduction
Stephen James Walsh is a notable inventor based in Cambridgeshire, GB. He has made significant contributions to the field of biotechnology, particularly through his innovative patent related to linkers and conjugates. His work has implications for the development of therapeutic agents.
Latest Patents
Stephen holds a patent for "Linkers and conjugates." This patent describes a conjugate that comprises a protein or a peptide, a linker, and an active agent. The linker includes a specific moiety of formula (III), where two of A, A, and A are nitrogen, and the other is carbon. The moiety is linked to the protein or peptide, either directly or indirectly, which enhances the functionality of the conjugate.
Career Highlights
Throughout his career, Stephen has worked with prominent companies such as AstraZeneca and Cambridge Enterprise Limited. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical industry.
Collaborations
Stephen has collaborated with notable individuals in his field, including Jeremy Stephen Parker and Hannah Fiona Sore. These partnerships have fostered innovation and have been instrumental in advancing their shared goals in biotechnology.
Conclusion
Stephen James Walsh is a distinguished inventor whose work in linkers and conjugates has the potential to impact therapeutic development significantly. His collaborations and career experiences further highlight his contributions to the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile